Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model. - Wikidata - wikimedia - TriplyDB

Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model.

Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model.

http://www.wikidata.org/entity/Q37686976

about

Progress and prospects of gene therapy clinical trials for the muscular dystrophies.Duchenne muscular dystrophy gene therapy in the canine model.piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.Viral vector-mediated gene therapies.Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.Gene Therapy with Adeno-associated Virus for Cystic Fibrosis.AAV6 Vector Production and Purification for Muscle Gene Therapy.

P2860

Q34497471-11936213-6820-4E3A-BC73-96CDCB894848 Q35641673-8C5870AB-DEB5-4B22-B803-9FB81B32B93F Q36532676-826E8384-F0A3-44EE-8E8D-5C9FF386EDA8 Q38564564-C1A57F52-BA30-4492-AC53-4F6C7F9F32F7 Q40109350-9CB73078-EFF1-41CC-ADE1-83F0D873EE2A Q45338599-F18456C8-B1BB-4D65-A5DF-8F816AFE73C9 Q45873577-D003D1ED-DEF8-4908-A659-AECF63F1A63E

P2860

Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model.

http://www.wikidata.org/entity/Q37686976

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Elimination of contaminating c ...... n a canine gene therapy model.

@en

Elimination of contaminating c ...... n a canine gene therapy model.

@nl

type

label

Elimination of contaminating c ...... n a canine gene therapy model.

@en

Elimination of contaminating c ...... n a canine gene therapy model.

@nl

prefLabel

Elimination of contaminating c ...... n a canine gene therapy model.

@en

Elimination of contaminating c ...... n a canine gene therapy model.

@nl

P1433

Q37686976-1A00FB6A-B030-4151-ABDC-6C1D0148EE6C

P1476

Q37686976-5616E577-D081-4C12-B127-480B05646B44

P2093

Q37686976-0E84E662-88AD-4541-851F-A807DD994E01

Q37686976-18A7B399-6A3D-43C4-A356-9EC89C8E29D5

Q37686976-599AB295-0A97-472A-82A2-381690B8A02E

Q37686976-6D06B371-116D-4761-B7EB-CCEF41C4B700

Q37686976-8C340D16-C8DA-4316-835C-3BB7DDDAE06F

Q37686976-934CF9C9-12D1-4E44-A1A2-6C6458AAB112

P2860

Q37686976-1A2ACB15-495D-47C9-9205-12AFF627EF27

Q37686976-1F4DE630-CCC0-4D08-9CEA-52E1E0B92684

Q37686976-29A470E8-AAC1-43E1-B79E-9AF94C712AB0

Q37686976-554F688F-77AA-4119-9BA1-D5EFC1893442

Q37686976-56B40D9A-698F-4B2F-953E-B83751474671

Q37686976-71562573-65F1-4124-A3B3-147B71CF22C5

Q37686976-7C8E14F6-EFCB-4F2D-9E0E-3ECD6318DFA5

Q37686976-8A48BBB5-951A-4CF8-975A-C5E09BC47469

Q37686976-8FB90278-15C5-420D-9DA8-61A6CAA44EBE

Q37686976-9245C8CD-C41E-4AF0-8CE2-87AE9D0248C6

P2888

Q37686976-B6EC5592-3298-4ECE-ACD5-C3D8609D9D46

P304

Q37686976-AB8B5D51-6B88-4DF6-A19E-06D9BD29CCF2

P31

Q37686976-C1264FF2-76C9-4818-8CB4-71BF80287430

P356

Q37686976-663C46F0-1F6A-42A6-9F62-99AE1DF5ECC9

P433

Q37686976-A2A35FD8-CBC8-48D5-A15A-D3A712710C03

P478

Q37686976-63D841A1-FD85-485D-AEE1-C472D321F8C1

P50

Q37686976-5F5BC14D-44D0-45F0-BD34-13818813CD9A

P577

Q37686976-FD8EE910-A5A4-47DC-B3D4-AEB253797F77

P5875

Q37686976-22C5C03C-CB9B-4F16-B7ED-4505353D198C

P6179

Q37686976-11AF8310-1776-4C5F-BE54-21F5FDADA5B8

P698

Q37686976-FFDE4AE0-D9A8-45CF-85EE-002625E57C9E

P921

Q37686976-BAE7A05B-A060-420E-A53F-7C2BD3FD370F

P932

Q37686976-72041EF4-63A0-488E-8C0E-C34F928CEBD9

P356

P1433

P1476

Elimination of contaminating c ...... n a canine gene therapy model.

@en

P2093

A D Miller

http://www.w3.org/2001/XMLSchema#string

C L Halbert

http://www.w3.org/2001/XMLSchema#string

D Lee

http://www.w3.org/2001/XMLSchema#string

S J Tapscott

http://www.w3.org/2001/XMLSchema#string

T Butts

http://www.w3.org/2001/XMLSchema#string

Z Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

Identification of mouse AAV capsid-specific CD8+ T cell epitopes.

Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging.

Mycophenolate mofetil and its mechanisms of action.

Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production.

Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo

Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies.

AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells

Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature.

P2888

P304

363-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2014.4

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Rainer F. Storb

P577

2014-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260117181

http://www.w3.org/2001/XMLSchema#string

P6179

1015450881

http://www.w3.org/2001/XMLSchema#string

P698

24500525

http://www.w3.org/2001/XMLSchema#string

P921

P932

3976967

http://www.w3.org/2001/XMLSchema#string